Ann Chen Wu1, Lingling Li2, Vicki Fung3, Elyse O Kharbanda4, Emma K Larkin5, Melissa G Butler6, Alison Galbraith7, Irina Miroshnik2, Robert L Davis8, Kelly Horan2, Tracy A Lieu9. 1. Center for Healthcare Research in Pediatrics, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Mass; Division of General Pediatrics, Department of Pediatrics, Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: ann.wu@childrens.harvard.edu. 2. Center for Healthcare Research in Pediatrics, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Mass. 3. Harvard Medical School, Boston, Mass; Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, Mass. 4. HealthPartners Institute for Education and Research, Minneapolis, Minn. 5. Vanderbilt University School of Medicine, Nashville, Tenn. 6. Center for Clinical Outcomes & Research - Southeast, Kaiser Permanente Georgia, Atlanta, Ga; The Argus Group, Hamilton, Bermuda. 7. Center for Healthcare Research in Pediatrics, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Mass; Division of General Pediatrics, Department of Pediatrics, Children's Hospital, Boston, Mass. 8. Center for Biomedical Informatics, University of Tennessee Health Sciences Center, Memphis, Tenn. 9. Division of Research, Kaiser Permanente Northern California, Oakland, Calif.
Abstract
BACKGROUND: Underuse of controller medicines among children with asthma remains widespread despite national guidelines. OBJECTIVES: To (1) assess provider prescribing patterns for asthma controller medications; (2) assess how frequently parents' reports of their child's asthma controller medicine use were mismatched with their provider's recommendations; and (3) evaluate parent attitudes and demographic characteristics associated with these mismatches. METHODS: In this cross-sectional study, we conducted linked surveys of parents and providers of children with probable persistent asthma in a Medicaid program and 4 commercial health plans in 2011. Probable persistent asthma was defined as a diagnosis of asthma and 1 or more controller medication dispensing. RESULTS: This study included 740 children (mean age, 8.6 years). Providers for 50% of the children reported prescribing controller medications for daily year-round use, 41% for daily use during active asthma months, and 9% for intermittent use for relief. Among parents, 72% knew which class of controller medication the provider prescribed and 49% knew the administration frequency and the medication class. Parents were less likely to report the same controller medication type as the provider, irrespective of dose and frequency, if they were Latino (odds ratio [OR], 0.23; CI, 0.057-0.90), had a household smoker (OR, 2.87; CI, 0.42-19.6), or believed the controller medicine was not helping (OR, 0.15; CI, 0.048-0.45). CONCLUSIONS: Mismatches between parent reports and providers intentions regarding how the child was supposed to use inhaled steroids occurred for half of the children. Efforts should focus on ways to reduce mismatches between parent and provider intentions regarding controller medication use.
BACKGROUND: Underuse of controller medicines among children with asthma remains widespread despite national guidelines. OBJECTIVES: To (1) assess provider prescribing patterns for asthma controller medications; (2) assess how frequently parents' reports of their child's asthma controller medicine use were mismatched with their provider's recommendations; and (3) evaluate parent attitudes and demographic characteristics associated with these mismatches. METHODS: In this cross-sectional study, we conducted linked surveys of parents and providers of children with probable persistent asthma in a Medicaid program and 4 commercial health plans in 2011. Probable persistent asthma was defined as a diagnosis of asthma and 1 or more controller medication dispensing. RESULTS: This study included 740 children (mean age, 8.6 years). Providers for 50% of the children reported prescribing controller medications for daily year-round use, 41% for daily use during active asthma months, and 9% for intermittent use for relief. Among parents, 72% knew which class of controller medication the provider prescribed and 49% knew the administration frequency and the medication class. Parents were less likely to report the same controller medication type as the provider, irrespective of dose and frequency, if they were Latino (odds ratio [OR], 0.23; CI, 0.057-0.90), had a household smoker (OR, 2.87; CI, 0.42-19.6), or believed the controller medicine was not helping (OR, 0.15; CI, 0.048-0.45). CONCLUSIONS: Mismatches between parent reports and providers intentions regarding how the child was supposed to use inhaled steroids occurred for half of the children. Efforts should focus on ways to reduce mismatches between parent and provider intentions regarding controller medication use.
Authors: L Keoki Williams; Edward L Peterson; Karen Wells; Brian K Ahmedani; Rajesh Kumar; Esteban G Burchard; Vimal K Chowdhry; David Favro; David E Lanfear; Manel Pladevall Journal: J Allergy Clin Immunol Date: 2011-10-21 Impact factor: 10.793
Authors: Michael A Fischer; Margaret R Stedman; Joyce Lii; Christine Vogeli; William H Shrank; M Alan Brookhart; Joel S Weissman Journal: J Gen Intern Med Date: 2010-02-04 Impact factor: 5.128
Authors: Stanley J Szefler; James W Baker; Tom Uryniak; Mitchell Goldman; Philip E Silkoff Journal: J Allergy Clin Immunol Date: 2007-11 Impact factor: 10.793
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Gregory S Sawicki; Lauren Smith; Barbara Bokhour; Charlene Gay; Katherine H Hohman; Alison A Galbraith; Tracy A Lieu Journal: Clin Pediatr (Phila) Date: 2008-01-11 Impact factor: 1.168
Authors: Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran Journal: J Allergy Clin Immunol Date: 2006-03 Impact factor: 10.793
Authors: Michelle Trivedi; Vicki Fung; Elyse O Kharbanda; Emma K Larkin; Melissa G Butler; Kelly Horan; Tracy A Lieu; Ann Chen Wu Journal: J Asthma Date: 2017-07-14 Impact factor: 2.515